SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-063614
Filing Date
2021-12-06
Accepted
2021-12-06 16:01:14
Documents
15
Period of Report
2021-12-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea151726-8k_citiuspharrm.htm   iXBRL 8-K 30792
2 PRESS RELEASE DATED DECEMBER 6, 2021. ea151726ex99-1_citiuspharrm.htm EX-99.1 14452
3 GRAPHIC image_001.jpg GRAPHIC 4477
  Complete submission text file 0001213900-21-063614.txt   273206

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ctxr-20211206.xsd EX-101.SCH 3729
5 XBRL DEFINITION FILE ctxr-20211206_def.xml EX-101.DEF 26590
6 XBRL LABEL FILE ctxr-20211206_lab.xml EX-101.LAB 36592
7 XBRL PRESENTATION FILE ctxr-20211206_pre.xml EX-101.PRE 25208
8 EXTRACTED XBRL INSTANCE DOCUMENT ea151726-8k_citiuspharrm_htm.xml XML 5347
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 211473203
SIC: 2834 Pharmaceutical Preparations